Your browser doesn't support javascript.
loading
MYPT1-PP1ß phosphatase negatively regulates both chromatin landscape and co-activator recruitment for beige adipogenesis.
Takahashi, Hiroki; Yang, Ge; Yoneshiro, Takeshi; Abe, Yohei; Ito, Ryo; Yang, Chaoran; Nakazono, Junna; Okamoto-Katsuyama, Mayumi; Uchida, Aoi; Arai, Makoto; Jin, Hitomi; Choi, Hyunmi; Tumenjargal, Myagmar; Xie, Shiyu; Zhang, Ji; Sagae, Hina; Zhao, Yanan; Yamaguchi, Rei; Nomura, Yu; Shimizu, Yuichi; Yamada, Kaito; Yasuda, Satoshi; Kimura, Hiroshi; Tanaka, Toshiya; Wada, Youichiro; Kodama, Tatsuhiko; Aburatani, Hiroyuki; Zhu, Min-Sheng; Inagaki, Takeshi; Osborne, Timothy F; Kawamura, Takeshi; Ishihama, Yasushi; Matsumura, Yoshihiro; Sakai, Juro.
Afiliação
  • Takahashi H; Division of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
  • Yang G; Division of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, 153-8904, Japan.
  • Yoneshiro T; Division of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
  • Abe Y; Division of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, 153-8904, Japan.
  • Ito R; Division of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, 153-8904, Japan.
  • Yang C; Division of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
  • Nakazono J; Division of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
  • Okamoto-Katsuyama M; Department of Molecular and Cellular BioAnalysis, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, 606-8501, Japan.
  • Uchida A; Division of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, 153-8904, Japan.
  • Arai M; Division of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, 153-8904, Japan.
  • Jin H; Division of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
  • Choi H; Division of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
  • Tumenjargal M; Division of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
  • Xie S; Division of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
  • Zhang J; Division of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
  • Sagae H; Division of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
  • Zhao Y; Division of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
  • Yamaguchi R; Division of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
  • Nomura Y; Division of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
  • Shimizu Y; Division of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
  • Yamada K; Division of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
  • Yasuda S; Division of Molecular Physiology and Metabolism, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
  • Kimura H; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
  • Tanaka T; Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, 980-8574, Japan.
  • Wada Y; Cell Biology Center, Institute of Innovative Research, Tokyo Institute of Technology, Yokohama, 226-8503, Japan.
  • Kodama T; Department of Nuclear Receptor Medicine, Laboratories for Systems Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, 153-8904, Japan.
  • Aburatani H; Isotope Science Center, The University of Tokyo, Tokyo, 113-0032, Japan.
  • Zhu MS; Department of Nuclear Receptor Medicine, Laboratories for Systems Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, 153-8904, Japan.
  • Inagaki T; Genome Science and Medicine Division, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, 153-8904, Japan.
  • Osborne TF; Model Animal Research Center and Ministry of Education (MOE) Key Laboratory of Model Animal for Disease Study, Nanjing University, 210061, Nanjing, China.
  • Kawamura T; Division of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo, Tokyo, 153-8904, Japan.
  • Ishihama Y; Laboratory of Epigenetics and Metabolism, Institute for Molecular and Cellular Regulation, Gunma University, Gunma, 371-8512, Japan.
  • Matsumura Y; Institute for Fundamental Biomedical Research, Johns Hopkins All Children's Hospital, and Medicine in the Division of Endocrinology, Diabetes and Metabolism of the Johns Hopkins University School of Medicine, 600 Fifth Street S. St., Petersburg, FL, 33701, USA.
  • Sakai J; Isotope Science Center, The University of Tokyo, Tokyo, 113-0032, Japan.
Nat Commun ; 13(1): 5715, 2022 09 29.
Article em En | MEDLINE | ID: mdl-36175407
ABSTRACT
Protein kinase A promotes beige adipogenesis downstream from ß-adrenergic receptor signaling by phosphorylating proteins, including histone H3 lysine 9 (H3K9) demethylase JMJD1A. To ensure homeostasis, this process needs to be reversible however, this step is not well understood. We show that myosin phosphatase target subunit 1- protein phosphatase 1ß (MYPT1-PP1ß) phosphatase activity is inhibited via PKA-dependent phosphorylation, which increases phosphorylated JMJD1A and beige adipogenesis. Mechanistically, MYPT1-PP1ß depletion results in JMJD1A-mediated H3K9 demethylation and activation of the Ucp1 enhancer/promoter regions. Interestingly, MYPT1-PP1ß also dephosphorylates myosin light chain which regulates actomyosin tension-mediated activation of YAP/TAZ which directly stimulates Ucp1 gene expression. Pre-adipocyte specific Mypt1 deficiency increases cold tolerance with higher Ucp1 levels in subcutaneous white adipose tissues compared to control mice, confirming this regulatory mechanism in vivo. Thus, we have uncovered regulatory cross-talk involved in beige adipogenesis that coordinates epigenetic regulation with direct activation of the mechano-sensitive YAP/TAZ transcriptional co-activators.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cromatina / Fosfatase de Miosina-de-Cadeia-Leve / Adipogenia Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cromatina / Fosfatase de Miosina-de-Cadeia-Leve / Adipogenia Limite: Animals Idioma: En Ano de publicação: 2022 Tipo de documento: Article